clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT02184416 |
P17 | country | Spain | Q29 |
Belgium | Q31 | ||
Italy | Q38 | ||
Austria | Q40 | ||
France | Q142 | ||
United Kingdom | Q145 | ||
P582 | end time | 2019-07-20 | |
P1050 | medical condition | carcinoma | Q33525 |
P2899 | minimum age | 18 | |
P1132 | number of participants | 750 | |
P4844 | research intervention | sirolimus | Q32089 |
P6153 | research site | Salamanca University Hospital | Q87762406 |
Barcelona Province | Q81949 | ||
Complutense University of Madrid | Q219694 | ||
Jean Perrin Center | Q2944826 | ||
Hôpital Lyon Sud | Q2945675 | ||
hôpital Foch | Q3145155 | ||
Clínica Universidad de Navarra | Q3297837 | ||
IRCCS Policlinico S. Matteo di Pavia | Q3747180 | ||
Residencia Sanitaria General Yagüe | Q5902662 | ||
Hospital de León | Q5903037 | ||
Hospital Universitario de Canarias | Q5908655 | ||
Royal Surrey County Hospital | Q7374889 | ||
Hospital General Universitario de Alicantet | Q16576057 | ||
Hospital Virgen de la Salud | Q30254321 | ||
Centre Hospitalier De Pau | Q50036402 | ||
??? | Q2945710 | ||
P1813 | short name | ADONIS | |
P580 | start time | 2014-10-31 | |
P8363 | study type | observational study | Q818574 |
P1476 | title | Axitinib In Advanced / Metastatic Renal Cell Carcinoma - A Non-interventional Study Of Real World Treatment Outcomes In Patients Receiving 2nd Line Axitinib After 1st Line Sunitinib (Adonis) |